PathologyWatch Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 62

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $150M

PathologyWatch General Information

Description

Developer of a digital pathology platform designed to detect and characterize cancers from biopsy samples. The company's platform takes histologic slides from any location and digitally distributes the work across a network of skilled experts who provide instant remote access to a workforce of academic-level dermatopathologists, digital tools, and expert consultation, enabling healthcare professionals to significantly become efficient in diagnosing skin cancer.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 370 South 300 East
  • Salt Lake City, UT 84111
  • United States
+1 (877)
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Decision/Risk Analysis
Other Healthcare Technology Systems
Parent Company
Corporate Office
  • 370 South 300 East
  • Salt Lake City, UT 84111
  • United States
+1 (877)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PathologyWatch Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 08-Jan-2024 $150M Completed Generating Revenue
8. General Corporate Purpose 17-Apr-2023 Completed Generating Revenue
7. Secondary Transaction - Private 30-Mar-2023 Completed Generating Revenue
6. Later Stage VC 06-Mar-2023 Completed Generating Revenue
5. Early Stage VC (Series B) 16-Nov-2021 Completed Generating Revenue
4. Accelerator/Incubator 30-May-2021 Completed Generating Revenue
3. Early Stage VC (Series A) 16-Dec-2020 Completed Generating Revenue
2. Seed Round 07-May-2019 $2.34M $2.34M Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view PathologyWatch’s complete valuation and funding history, request access »

PathologyWatch Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
Seed-2 87,379 $0.000100 $7 $7 1x $7 3.29%
Seed-1 270,383 $0.000100 $10.36 $10.36 1x $10.36 10.19%
To view PathologyWatch’s complete cap table history, request access »

PathologyWatch Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a digital pathology platform designed to detect and characterize cancers from biopsy samples. The company's
Laboratory Services (Healthcare)
Salt Lake City, UT
62 As of 2024

Albuquerque, NM
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PathologyWatch Competitors (1)

One of PathologyWatch’s competitors is Indica Labs, a Venture Capital-Backed company based in Albuquerque, NM.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Indica Labs Venture Capital-Backed Albuquerque, NM
You’re viewing 1 of 1 competitors. Get the full list »

PathologyWatch Patents

PathologyWatch Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250061983-A1 Systems, methods, and devices for a cancer pathology laboratory information system (lis) Pending 19-Aug-2023
US-20250061984-A1 Dynamic cancer pathology laboratory information systems, methods, and devices Pending 19-Aug-2023
US-20240321449-A1 Systems, methods, and devices for melanoma pathology using one or more neural networks Pending 24-Mar-2023 G16H50/20

PathologyWatch Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PathologyWatch Former Investors (24)

Investor Name Investor Type Holding Investor Since Participating Rounds
37 Angels Angel Group Minority
AWS Startups Accelerator/Incubator
Angel (individual) Minority
Beni Venture Capital Impact Investing Minority
BioVentures Investors Venture Capital Minority
You’re viewing 5 of 24 investors. Get the full list »

PathologyWatch FAQs

  • When was PathologyWatch founded?

    PathologyWatch was founded in 2017.

  • Where is PathologyWatch headquartered?

    PathologyWatch is headquartered in Salt Lake City, UT.

  • What is the size of PathologyWatch?

    PathologyWatch has 62 total employees.

  • What industry is PathologyWatch in?

    PathologyWatch’s primary industry is Laboratory Services (Healthcare).

  • Is PathologyWatch a private or public company?

    PathologyWatch is a Private company.

  • What is the current valuation of PathologyWatch?

    The current valuation of PathologyWatch is .

  • What is PathologyWatch’s current revenue?

    The current revenue for PathologyWatch is .

  • How much funding has PathologyWatch raised over time?

    PathologyWatch has raised $57.2M.

  • Who are PathologyWatch’s investors?

    37 Angels, AWS Startups, , Beni Venture Capital, and BioVentures Investors are 5 of 24 investors who have invested in PathologyWatch.

  • Who are PathologyWatch’s competitors?

    Indica Labs is a competitor of PathologyWatch.

  • When was PathologyWatch acquired?

    PathologyWatch was acquired on 08-Jan-2024.

  • Who acquired PathologyWatch?

    PathologyWatch was acquired by Sonic Healthcare.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »